Bénédicte Brounais-Le-Royer

8PUBLICATIONS
38CO-AUTHORS
Predictive and prognostic markersCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 20, 2026
Dysregulated AKT signaling reprograms osteosarcoma to drive selective reliance on EP300.

|Nov 02, 2024
Chimeric protein EWS::FLI1 drives cell proliferation in Ewing Sarcoma via aberrant expression of KCNN1/SK1 and dysregulation of calcium signaling.

Maryne Dupuy, Maxime Gueguinou, Anaïs Postec

|Dec 11, 2022
The p53 Family Members p63 and p73 Roles in the Metastatic Dissemination: Interactions with microRNAs and TGFβ Pathway.

Lidia Rodriguez Calleja, Melanie Lavaud, Robel Tesfaye

|Nov 26, 2022
TRAIL-Based Therapies Efficacy in Pediatric Bone Tumors Models Is Modulated by TRAIL Non-Apoptotic Pathway Activation via RIPK1 Recruitment.

Régis Brion, Malika Gantier, Kevin Biteau

|Apr 12, 2022
Inhibiting Endothelin Receptors with Macitentan Strengthens the Bone Protective Action of RANKL Inhibition and Reduces Metastatic Dissemination in Osteosarcoma.

Javier Muñoz-Garcia, Jorge William Vargas-Franco, Bénédicte Brounais-Le Royer

|Sep 28, 2021
Overexpression of the Ubiquitin Specific Proteases USP43, USP41, USP27x and USP6 in Osteosarcoma Cell Lines: Inhibition of Osteosarcoma Tumor Growth and Lung Metastasis Development by the USP Antagonist PR619.

Mélanie Lavaud, Mathilde Mullard, Robel Tesfaye

Pageof 2

Frequent Collaborators

5 joint publications

Franck Verrecchia

4 joint publications

Benjamin Ory

2 joint publications

Dominique Heymann

2 joint publications

Frédéric Lézot